NCT07162467View on ClinicalTrials.gov

Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Schizophrenia
Trial Locations (1)

Unknown

Tianjin Anding Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Anding Hospital

OTHER